BENIGN PROSTATIC HYPERPLASIA
Clinical trials for BENIGN PROSTATIC HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BENIGN PROSTATIC HYPERPLASIA trials appear
Sign up with your email to follow new studies for BENIGN PROSTATIC HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to stop bleeding, speed recovery from common prostate surgery
Disease control Not yet recruitingThis study is testing if a drug called tranexamic acid (TXA) can reduce bleeding during a common prostate surgery for enlarged prostate (BPH). It will involve 80 men who are randomly given either the drug or a placebo (inactive solution) before their surgery. The main goal is to …
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Phase: PHASE4 • Sponsor: Hamza Najout • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Smart belt could track bladder health from home
Diagnosis Not yet recruitingThis study is testing a new wearable device that aims to monitor how well the bladder empties in men with an enlarged prostate (BPH). The device is worn on the lower abdomen and uses a safe, non-invasive imaging technique. Researchers will compare its readings to the standard cli…
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
New gel aims to stop bleeding, send prostate patients home same day
Symptom relief Not yet recruitingThis study is testing if applying a special gel called PuraStat after a water-based prostate surgery (Aquablation) can reduce post-operative bleeding. The main goal is to see if this reduction in bleeding allows more patients to be safely discharged to go home on the same day as …
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Head-to-Head: which prostate pill works better?
Symptom relief Not yet recruitingThis study aims to find out which of two existing medications, Silodosin or Tamsulosin, works better and is safer for easing urinary problems caused by an enlarged prostate. It will involve 140 men over 50 who have moderate to severe symptoms. Each participant will try both medic…
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Phase: PHASE4 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Early test for enlarged prostate drug begins in healthy men
Knowledge-focused Not yet recruitingThis early-stage study aims to compare the safety and how the body processes two different versions of a drug being developed for an enlarged prostate (BPH). It will involve 44 healthy adult male volunteers. The main goal is to see how much of each drug version gets into the bloo…
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC
-
Simple pee test could reveal who benefits most from prostate surgery
Knowledge-focused Not yet recruitingThis study aims to see if a specific protein (CTGF) found in urine can tell doctors how much scarring (fibrosis) is in a man's bladder before surgery for an enlarged prostate. Researchers will check the urine of 50 men before their operation and see if the protein level predicts …
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Sponsor: Tarik Emre Sener • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC
-
Scientists track how pee problems predict other illnesses in seniors
Knowledge-focused Not yet recruitingThis study aims to understand the relationship between urinary function (like bladder control and flow) and the development of other common age-related health problems, such as diabetes, heart disease, and high blood pressure. It will follow 500 Beijing residents aged 60 and olde…
Matched conditions: BENIGN PROSTATIC HYPERPLASIA
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:52 UTC